Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India

Background:       Beta-hemolytic streptococci (BHS) are responsible for both invasive and noninvasive infections, and the preferred treatment for these infections is penicillin due to the distinctive characteristics of these bacteria. However, in patients who cannot tolerate β-lactam antibi...

Full description

Bibliographic Details
Main Authors: Ann George, Rosmi Jose, Chithra Valsan
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-09-01
Series:Journal of Medical Bacteriology
Subjects:
Online Access:https://jmb.tums.ac.ir/index.php/jmb/article/view/492
_version_ 1827821040268476416
author Ann George
Rosmi Jose
Chithra Valsan
author_facet Ann George
Rosmi Jose
Chithra Valsan
author_sort Ann George
collection DOAJ
description Background:       Beta-hemolytic streptococci (BHS) are responsible for both invasive and noninvasive infections, and the preferred treatment for these infections is penicillin due to the distinctive characteristics of these bacteria. However, in patients who cannot tolerate β-lactam antibiotics, macrolides and clindamycin are important alternative options for treating BHS infections. This study aimed to analyse the pattern of macrolide resistance among clinical strains of beta-hemolytic streptococci (BHS). Methods:      Beta hemolytic streptococci isolated from clinical specimens during December 2018 to May 2020 were included in this study. Identification of the isolates were done by conventional and Vitek 2 method. All isolates were subjected to serogrouping. Antibiotic susceptibility testing done by disc diffusion method. Genes encoding macrolide resistance were detected by conventional multiplex polymerase chain reaction. Results:      A total of 129 beta hemolytic streptococcal isolates were obtained which included 27 S. pyogenes (20.9%), 77 S.agalactiae (59.7%), 23  S.dysgalactiae spp equisimilis (17.8%) and one isolate of S.anginosus and  S. porcinus each (0.8%). Erythromycin, clindamycin, quinuprisitn and tetracycline resistance were found to be 20.2%, 12.1%, 16.3% and 51.2% respectively. Among the 26 erythromycin resistant isolates, 12(46.2%) were inducible clindamycin resistant phenotype.  Out of 26 erythromycin resistant isolates, 7(26.9%) isolates were harbouring erm(A) gene, 10(38.5%) erm(B) and 9(34.6%) mef(A) gene. Conclusion:      Our study highlights the importance of routine antibiotic susceptibility testing for beta-haemolytic streptococci, as well as the detection of inducible resistance to prevent therapeutic failure.
first_indexed 2024-03-12T01:37:47Z
format Article
id doaj.art-ff710c02de424063a7d5c5eda1be2372
institution Directory Open Access Journal
issn 2251-8649
2322-2581
language English
last_indexed 2024-03-12T01:37:47Z
publishDate 2023-09-01
publisher Tehran University of Medical Sciences
record_format Article
series Journal of Medical Bacteriology
spelling doaj.art-ff710c02de424063a7d5c5eda1be23722023-09-11T05:13:57ZengTehran University of Medical SciencesJournal of Medical Bacteriology2251-86492322-25812023-09-01113-4Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, IndiaAnn George0Rosmi Jose1Chithra Valsan2Department of Microbiology, Jubilee Mission Medical College & Research Institute, Thrissur, Kerala, India.JUBILEE MISSION MEDICAL COLLEGE & RESEARCH INSTITUTE , THRISSUR, KERALADepartment of Microbiology, Jubilee Mission Medical College & Research Institute, Thrissur, Kerala, India. Background:       Beta-hemolytic streptococci (BHS) are responsible for both invasive and noninvasive infections, and the preferred treatment for these infections is penicillin due to the distinctive characteristics of these bacteria. However, in patients who cannot tolerate β-lactam antibiotics, macrolides and clindamycin are important alternative options for treating BHS infections. This study aimed to analyse the pattern of macrolide resistance among clinical strains of beta-hemolytic streptococci (BHS). Methods:      Beta hemolytic streptococci isolated from clinical specimens during December 2018 to May 2020 were included in this study. Identification of the isolates were done by conventional and Vitek 2 method. All isolates were subjected to serogrouping. Antibiotic susceptibility testing done by disc diffusion method. Genes encoding macrolide resistance were detected by conventional multiplex polymerase chain reaction. Results:      A total of 129 beta hemolytic streptococcal isolates were obtained which included 27 S. pyogenes (20.9%), 77 S.agalactiae (59.7%), 23  S.dysgalactiae spp equisimilis (17.8%) and one isolate of S.anginosus and  S. porcinus each (0.8%). Erythromycin, clindamycin, quinuprisitn and tetracycline resistance were found to be 20.2%, 12.1%, 16.3% and 51.2% respectively. Among the 26 erythromycin resistant isolates, 12(46.2%) were inducible clindamycin resistant phenotype.  Out of 26 erythromycin resistant isolates, 7(26.9%) isolates were harbouring erm(A) gene, 10(38.5%) erm(B) and 9(34.6%) mef(A) gene. Conclusion:      Our study highlights the importance of routine antibiotic susceptibility testing for beta-haemolytic streptococci, as well as the detection of inducible resistance to prevent therapeutic failure. https://jmb.tums.ac.ir/index.php/jmb/article/view/492Beta hemolytic StreptococciMacrolide resistanceInducible clindamycin resistanceGenotypes
spellingShingle Ann George
Rosmi Jose
Chithra Valsan
Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
Journal of Medical Bacteriology
Beta hemolytic Streptococci
Macrolide resistance
Inducible clindamycin resistance
Genotypes
title Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
title_full Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
title_fullStr Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
title_full_unstemmed Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
title_short Prevalence and Molecular Characterization of Macrolide Resistance in Clinical Isolates of Beta Hemolytic Streptococci from a Tertiary Care Teaching Hospital in Kerala, India
title_sort prevalence and molecular characterization of macrolide resistance in clinical isolates of beta hemolytic streptococci from a tertiary care teaching hospital in kerala india
topic Beta hemolytic Streptococci
Macrolide resistance
Inducible clindamycin resistance
Genotypes
url https://jmb.tums.ac.ir/index.php/jmb/article/view/492
work_keys_str_mv AT anngeorge prevalenceandmolecularcharacterizationofmacrolideresistanceinclinicalisolatesofbetahemolyticstreptococcifromatertiarycareteachinghospitalinkeralaindia
AT rosmijose prevalenceandmolecularcharacterizationofmacrolideresistanceinclinicalisolatesofbetahemolyticstreptococcifromatertiarycareteachinghospitalinkeralaindia
AT chithravalsan prevalenceandmolecularcharacterizationofmacrolideresistanceinclinicalisolatesofbetahemolyticstreptococcifromatertiarycareteachinghospitalinkeralaindia